This week, LTR Pharma’s Executive Chairman, Lee Rodne, spoke with Juliette Saly from ausbiz to discuss the Company’s progress in the advancement of rapid treatment for Erectile Dysfunction (ED), SPONTAN®, including the commencement of recruitment for its pivotal bioequivalence study.

Take a look: